Cargando…

Significance of genetic sequencing in patients with lung adenocarcinoma with transformation to small cell lung cancer: a case report and systematic review

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) exhibit a beneficial therapeutic effect on non-small cell lung cancer (NSCLC). However, almost all patients with EGFR-mutant lung cancer develop drug resistance to these agents. Common drug resistance mechanisms include the T790...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Cuicui, Lin, Li, Guo, Xin, Chen, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798927/ https://www.ncbi.nlm.nih.gov/pubmed/35117735 http://dx.doi.org/10.21037/tcr-19-2291

Ejemplares similares

Small-cell lung carcinoma transformation of lung adenocarcinoma diagnosed by pericardial effusion: A case report
por: Otoshi, Ryota, et al.
Publicado: (2020)

Ureteral metastasis of small cell lung cancer transformed from lung adenocarcinoma: A case report
por: Wang, Yi, et al.
Publicado: (2022)

Whole exome sequencing (WES) analysis of transformed small cell lung cancer (SCLC) from lung adenocarcinoma (LUAD)
por: Xie, Tongji, et al.
Publicado: (2020)

Small cell lung cancer transformation after EGFR-TKIs treatment in lung adenocarcinoma: A case report and literatures review
por: Chen, Xiaoli, et al.
Publicado: (2023)

The clinicopathologic of pulmonary adenocarcinoma transformation to small cell lung cancer
por: Yang, Haiyan, et al.
Publicado: (2019)

Combined Small and Squamous Transformation in EGFR-mutated Lung Adenocarcinoma
por: Hakozaki, Taiki, et al.
Publicado: (2020)

Small-Cell Lung Cancer Transformation in Patients With Pulmonary Adenocarcinoma: A Case Report and Review of Literature
por: Jiang, Shi-Yu, et al.
Publicado: (2016)

Small-cell transformation of ALK-rearranged non-small-cell adenocarcinoma of the lung
por: Balla, Agnes, et al.
Publicado: (2018)

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
por: Niederst, Matthew J., et al.
Publicado: (2015)

Case report: Clinical management of recurrent small cell lung cancer transformation complicated with lung cancer-induced acute pancreatitis after lung adenocarcinoma surgery
por: Zhang, Suyun, et al.
Publicado: (2023)

Adenocarcinoma of the Lung Acquiring Resistance to Afatinib by Transformation to Small Cell Carcinoma: A Case Report
por: Nishimura, Jun, et al.
Publicado: (2017)

Histological transformation of lung adenocarcinoma to small cell lung cancer with mutant C797S conferring acquired resistance to osimertinib
por: Ren, Xiaohui, et al.
Publicado: (2020)

Application of the Next-Generation Sequencing Technology to Reveal Mechanism of Small Cell Lung Cancer Transformation from Adenocarcinoma
por: Zhou, Yong-Zhao, et al.
Publicado: (2018)

Clinicopathological features of patients with transformation from EGFR mutant lung adenocarcinoma to small cell lung cancer
por: Bai, Wenwen, et al.
Publicado: (2021)

Genetic Alteration and Their Significance on Clinical Events in Small Cell Lung Cancer
por: Jiao, Shuyue, et al.
Publicado: (2022)

Outcomes in Patients With Lung Adenocarcinoma With Transformation to Small Cell Lung Cancer After EGFR Tyrosine Kinase Inhibitors Resistance: A Systematic Review and Pooled Analysis
por: Xu, Jinhe, et al.
Publicado: (2022)

Oncogenic role of epithelial cell transforming sequence 2 in lung adenocarcinoma cells
por: Tan, Hongyi, et al.
Publicado: (2016)

Oncogenic role of epithelial cell transforming sequence 2 in lung adenocarcinoma cells
por: Tan, Hongyi, et al.
Publicado: (2021)

Sequential occurrence of T790M mutation and small cell lung cancer transformation in EGFR-positive lung adenocarcinoma: A case report
por: Hong, Er, et al.
Publicado: (2022)

Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review
por: Leonetti, Alessandro, et al.
Publicado: (2021)

Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinoma
por: Wu, Xiaonan, et al.
Publicado: (2022)

Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases
por: Ahn, Soomin, et al.
Publicado: (2016)

Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance: A case report
por: Jiang, Yiqian, et al.
Publicado: (2021)

Clinical significance of gefitinib antitumor activity in patients with lung adenocarcinoma
por: WANG, ZHUN, et al.
Publicado: (2015)

Response to tyrosine kinase inhibitors in lung adenocarcinoma with the rare epidermal growth factor receptor mutation S768I and G724S: A case report and literature review
por: Zhang, Cuicui, et al.
Publicado: (2020)

Transformation of non-small cell lung cancer into small cell lung cancer in a patient with advanced lung cancer: a case report
por: Yang, Zhengyuan, et al.
Publicado: (2021)

Clinicopathologic and molecular characteristics of EGFR-mutant lung adenocarcinomas that transform to small cell lung cancer after TKI therapy
por: Yu, Li, et al.
Publicado: (2022)

Case report: A case report and literature review about Pathological transformation of lung adenosquamous cell carcinoma
por: Ge-ge, Liang, et al.
Publicado: (2022)

Clinical significance of STING expression and methylation in lung adenocarcinoma based on bioinformatics analysis
por: lin, Ze, et al.
Publicado: (2022)

Prognostic significance of pyroptosis-related factors in lung adenocarcinoma
por: Lin, Ximing, et al.
Publicado: (2022)

The Significance of Serum Carcinoembryonic Antigen in Lung Adenocarcinoma
por: Kim, Jae Jun, et al.
Publicado: (2015)

Case report: TP53 and RB1 loss may facilitate the transformation from lung adenocarcinoma to small cell lung cancer by expressing neuroendocrine markers
por: Li, Jun, et al.
Publicado: (2022)

Identification of a small mutation panel of coding sequences to predict the efficacy of immunotherapy for lung adenocarcinoma
por: Li, Ying, et al.
Publicado: (2020)

Small cell lung cancer transformation during antitumor therapies: A systematic review
por: Chai, Xing, et al.
Publicado: (2021)

Hyperprogressive Disease in Lung Cancer with Transformation of Adenocarcinoma to Small-cell Carcinoma during Pembrolizumab Therapy
por: Okeya, Komugi, et al.
Publicado: (2019)

Bioinformatics-based screening of key genes for transformation of tyrosine kinase inhibitor-resistant lung adenocarcinoma to small cell lung cancer
por: Zhang, Ying, et al.
Publicado: (2023)

Lgr5-positive cells in the lung and their clinical significance in patients with lung adenocarcinoma
por: Zhang, Xiaohan, et al.
Publicado: (2016)

Prognostic Significance of Phosphorylated Fyn in Patients with Lung Adenocarcinoma after Lung Resection
por: Nishikawa, Shigeto, et al.
Publicado: (2019)

Prognostic significance of cribriform adenocarcinoma of the lung: validation analysis of 1,057 Japanese patients with resected lung adenocarcinoma and a review of the literature
por: Nakajima, Naoki, et al.
Publicado: (2021)

Identification of Small Nucleolar RNA SNORD60 as a Potential Biomarker and Its Clinical Significance in Lung Adenocarcinoma
por: Zhou, Hongwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s393elihp6eikv9fghne39tted